The Braskie Research Group The Braskie Research Group focuses on the neuroimaging of risk for Alzheimer’s disease and related dementias (ADRD). We are particularly interested in how metabolic and vascular risk and immune function relate to brain changes associated with ADRD risk, and how those relationships are the same or different across demographic groups and neuropathological stages. To do this, we relate risk factors, fluid biomarkers, and relevant demographic data to multimodal neuroimaging measures, including from structural, functional, and diffusion magnetic resonance imaging (MRI) and amyloid and tau positron emission tomography (PET).
To learn more about our work, please check out our publications
And our social media pages:
https://x.com/MeredithBraskie
https://bsky.app/profile/meredithbraskie.bsky.social
https://www.linkedin.com/in/meredith-braskie-1a3870321/